These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1320 related articles for article (PubMed ID: 9099745)
101. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Lundberg AS; Weinberg RA Mol Cell Biol; 1998 Feb; 18(2):753-61. PubMed ID: 9447971 [TBL] [Abstract][Full Text] [Related]
102. Transforming growth factor beta targeted inactivation of cyclin E:cyclin-dependent kinase 2 (Cdk2) complexes by inhibition of Cdk2 activating kinase activity. Nagahara H; Ezhevsky SA; Vocero-Akbani AM; Kaldis P; Solomon MJ; Dowdy SF Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14961-6. PubMed ID: 10611320 [TBL] [Abstract][Full Text] [Related]
103. Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes. Steiner P; Philipp A; Lukas J; Godden-Kent D; Pagano M; Mittnacht S; Bartek J; Eilers M EMBO J; 1995 Oct; 14(19):4814-26. PubMed ID: 7588611 [TBL] [Abstract][Full Text] [Related]
104. Use of normal and transgenic mice to examine the relationship between terminal differentiation of intestinal epithelial cells and accumulation of their cell cycle regulators. Chandrasekaran C; Coopersmith CM; Gordon JI J Biol Chem; 1996 Nov; 271(45):28414-21. PubMed ID: 8910466 [TBL] [Abstract][Full Text] [Related]
105. Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivo. Gómez Lahoz E; Liegeois NJ; Zhang P; Engelman JA; Horner J; Silverman A; Burde R; Roussel MF; Sherr CJ; Elledge SJ; DePinho RA Mol Cell Biol; 1999 Jan; 19(1):353-63. PubMed ID: 9858559 [TBL] [Abstract][Full Text] [Related]
106. The protein SET regulates the inhibitory effect of p21(Cip1) on cyclin E-cyclin-dependent kinase 2 activity. Estanyol JM; Jaumot M; Casanovas O; Rodriguez-Vilarrupla A; Agell N; Bachs O J Biol Chem; 1999 Nov; 274(46):33161-5. PubMed ID: 10551888 [TBL] [Abstract][Full Text] [Related]
107. The proto-oncogene c-myc acts through the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) to facilitate the activation of Cdk4/6 and early G(1) phase progression. Obaya AJ; Kotenko I; Cole MD; Sedivy JM J Biol Chem; 2002 Aug; 277(34):31263-9. PubMed ID: 12070150 [TBL] [Abstract][Full Text] [Related]
108. Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a). Mitra J; Dai CY; Somasundaram K; El-Deiry WS; Satyamoorthy K; Herlyn M; Enders GH Mol Cell Biol; 1999 May; 19(5):3916-28. PubMed ID: 10207115 [TBL] [Abstract][Full Text] [Related]
109. Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2. Aikawa T; Segre GV; Lee K J Biol Chem; 2001 Aug; 276(31):29347-52. PubMed ID: 11384971 [TBL] [Abstract][Full Text] [Related]
110. Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2. Gorospe M; Liu Y; Xu Q; Chrest FJ; Holbrook NJ Mol Cell Biol; 1996 Mar; 16(3):762-70. PubMed ID: 8622677 [TBL] [Abstract][Full Text] [Related]
111. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Harper JW; Adami GR; Wei N; Keyomarsi K; Elledge SJ Cell; 1993 Nov; 75(4):805-16. PubMed ID: 8242751 [TBL] [Abstract][Full Text] [Related]
112. Calmodulin is essential for cyclin-dependent kinase 4 (Cdk4) activity and nuclear accumulation of cyclin D1-Cdk4 during G1. Taulés M; Rius E; Talaya D; López-Girona A; Bachs O; Agell N J Biol Chem; 1998 Dec; 273(50):33279-86. PubMed ID: 9837900 [TBL] [Abstract][Full Text] [Related]
113. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Lukas J; Bartkova J; Rohde M; Strauss M; Bartek J Mol Cell Biol; 1995 May; 15(5):2600-11. PubMed ID: 7739541 [TBL] [Abstract][Full Text] [Related]
114. sst2 somatostatin receptor mediates cell cycle arrest and induction of p27(Kip1). Evidence for the role of SHP-1. Pagès P; Benali N; Saint-Laurent N; Estève JP; Schally AV; Tkaczuk J; Vaysse N; Susini C; Buscail L J Biol Chem; 1999 May; 274(21):15186-93. PubMed ID: 10329727 [TBL] [Abstract][Full Text] [Related]
115. Caspase 3-mediated cleavage of p21WAF1/CIP1 associated with the cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells. Jin YH; Yoo KJ; Lee YH; Lee SK J Biol Chem; 2000 Sep; 275(39):30256-63. PubMed ID: 10884382 [TBL] [Abstract][Full Text] [Related]
116. Inhibition of cyclin E-cyclin-dependent kinase 2 complex formation and activity is associated with cell cycle arrest and withdrawal in oligodendrocyte progenitor cells. Ghiani C; Gallo V J Neurosci; 2001 Feb; 21(4):1274-82. PubMed ID: 11160398 [TBL] [Abstract][Full Text] [Related]
117. ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency. Lane HA; Beuvink I; Motoyama AB; Daly JM; Neve RM; Hynes NE Mol Cell Biol; 2000 May; 20(9):3210-23. PubMed ID: 10757805 [TBL] [Abstract][Full Text] [Related]
118. Requirement of cyclin E-Cdk2 inhibition in p16(INK4a)-mediated growth suppression. Jiang H; Chou HS; Zhu L Mol Cell Biol; 1998 Sep; 18(9):5284-90. PubMed ID: 9710613 [TBL] [Abstract][Full Text] [Related]
119. Differential requirements for interleukin-2 distinguish the expression and activity of the cyclin-dependent kinases Cdk4 and Cdk2 in human T cells. Modiano JF; Domenico J; Szepesi A; Lucas JJ; Gelfand EW J Biol Chem; 1994 Dec; 269(52):32972-8. PubMed ID: 7806527 [TBL] [Abstract][Full Text] [Related]